SynthesisFrontiers in pharmacology2022

A systematic review and network meta-analysis of the efficacy and safety of third-line and over third-line therapy after imatinib and TKI resistance in advanced gastrointestinal stromal tumor.

Xianhao Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.